Abstract:Abstract A 7-year-old female with type IV skin and autism spectrum disorder presented with a 4 month history of progressive proximal myopathy, weight loss and 20 month history of a worsening, intensely pruritic rash. Cutaneous examination showed a widespread eczematous eruption, post-inflammatory hypopigmentation, heliotrope rash and firm subcutaneous changes, in addition to palmar-plantar papules, pustules and burrows. Extra-cutaneous findings included multiple fixed flexion deformities and muscle wasting. Investigations revealed a normocytic anaemia, elevated muscle enzymes, strongly positive anti-nuclear antibodies and negative myositis-specific antibodies. Whole body MRI reported proximal muscle oedema. Skin biopsy demonstrated lichenoid and perifollicular inflammation, dermal mucin and subcutaneous calcification. Clinical findings were consistent with a diagnosis of juvenile dermatomyositis (JDM), complicated by concurrent scabies. Prednisolone in combination with methotrexate was commenced as first-line therapy in line with current consensus JDM treatment plans, in addition to topical steroids and sun protection. Muscle power started to improve after 5 months but ongoing cutaneous inflammation prompted second-line therapy with IV immunoglobulin. Oral ivermectin was required for the management of scabies due to topical permethrin failure. JDM is a rare autoimmune small-vessel vasculopathy with significant morbidity and limited evidence-based guidelines. Unlike adult-onset disease there is no racial predilection or association with malignancy. Calcinosis is more common in children but early treatment reduces disease complications. JDM has a variable disease course with a median time to remission of 4.67 years. Residual skin changes are increasingly recognised to be an early predictor of prolonged recovery time and these patients may benefit from biologic agents.

Mining for Gems: Early Detection of Calcinosis in Juvenile Dermatomyositis Using Low-Dose Computed Tomography

Assessment of Thigh MRI Radiomics and Clinical Characteristics for Assisting in Discrimination of Juvenile Dermatomyositis.

Application of HRCT-based radiomics to predict interstitial lung disease for juvenile dermatomyositis

Whole-body MRI: a helpful diagnostic tool for juvenile dermatomyositis case report and review of the literature

Janus Kinase Inhibitor, Tofacitinib, in Refractory Juvenile Dermatomyositis: a Retrospective Multi-Central Study in China

Treatment of Calcinosis in Dermatomyositis—Case Report and Review

Progression in the study of Juvenile dermatomyositis

Rare skin manifestation of juvenile dermatomyositis: peri-orbital oedema and facial swelling

Juvenile Dermatomyositis: Diagnosis and Management

Radiomics-based Method for Diagnosis of Calciphylaxis in Patients with Chronic Kidney Disease Using Computed Tomography.

Hard as stone: an exuberant form of calcinosis cutis

Unveiling Cardiac Involvement in Juvenile Dermatomyositis Through Speckle-Tracking Echocardiography

Anti-nuclear Matrix Protein 2+ Juvenile Dermatomyositis with Severe Skin Ulcer and Infection: A Case Report and Literature Review

Calcinosis with sinuses caused by dermatomyositis.

O08 Severely pruritic juvenile dermatomyositis

Cutaneous Ulceration in Juvenile Dermatomyositis with Anti-Melanoma Differentiation-Associated Gene 5

Juvenile dermatomyositis complications: navigating gastrointestinal perforations and treatment challenges, a case report

P15 A Case of Juvenile Dermatomyositis in a 15-year old African-descent Girl

Local injection of infliximab into calcinosis lesions in patients with juvenile dermatomyositis (JDM): a clinical trial

Clinical comparative analysis of juvenile dermatomyositis and adult dermatomyositis

Longitudinal assessment of disease activity and muscle strength in juvenile dermatomyositis: a multicentre registry study